Locate Bio has closed a funding round worth approximately $14m (£10m), intended to further advance Locate’s line of regenerative orthobiologics products.
The financing round, announced on 3 September, is led by Mercia
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?